Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
75 61 88 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
Insufficient record: 2 predictions resolved, 5 needed for a score.
All types combined: 75 (likely 61 to 88, low confidence), from 12 claims: 12 factual claims. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Jim Cramer's claims
30 claims
“You don't buy the stock of Lilly here — the stock jumped nearly 15% yesterday, for heaven's sake.”
Jim Cramer, CNBC host 9 August 2023 Cramer says investors need to buy stock before its big move, not after (CNBC)
Eli Lilly's stock jumped nearly 15% on the trading day before 2023-08-09.
Resolved true The record shows it happened or was so.
What would count as true or false
Judge Eli Lilly's (LLY) close-to-close percentage change on 2023-08-08, the trading day before 2023-08-09. True: a gain of about 13.5% to 15.5%. Mostly true: a gain of 12% to under 13.5%, or above 15.5% up to 17%, or the gain was about 15% but on a different nearby day. Mostly false: a gain of 8% to under 12%, or above 17%. False: a gain under 8%, or a decline.
Evidence
- Lilly (Eli) (LLY) — Earnings History & Price Movement wsfriend.com
“Its largest post-earnings gain was +14.87% (Aug 08, 2023) and its largest decline was -14.14% (Aug 07, 2025).”
- Lilly market value soars on higher sales, obesity drug potential BioPharma Dive · 8 August 2023
“Shares jumped 15% on second quarter earnings that showed the company’s revenue rose by 28%, driven by fast sales of its diabetes medicine Mounjaro.”
- Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap Zacks Investment Research (via TradingView) · 9 August 2023
“The stock soared 15% to heights not seen since the early 2000s, adding $64 billion to its market cap.”
Reasoning
E1 records Eli Lilly's largest post-earnings gain as +14.87% on Aug 08, 2023. That falls within the 13.5%–15.5% range the criteria set for a true verdict. E2 (dated 2023-08-08) and E3 (dated 2023-08-09) are both independent, and each reports that the shares jumped or soared about 15% on second-quarter earnings. Together the three sources show a gain of nearly 15% on 2023-08-08.
Cite this claim
Jim Cramer, “Eli Lilly's stock jumped nearly 15% on the trading day before 2023-08-09.” (said 9 August 2023). Verdict: resolved true. Reliability API, claim c_2b027ba25a68, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_2b027ba25a68
Claims without a verdict
Is a verdict here wrong, or do you speak for Jim Cramer? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.